Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.
about
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South AfricaHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaImmunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.A Simple Phosphate-Buffered-Saline-Based Extraction Method Improves Specificity of HIV Viral Load Monitoring Using Dried Blood Spots.Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeA clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho.Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.Association of first-line and second-line antiretroviral therapy adherence.Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria.Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.Persistent difficulties in switching to second-line ART in sub-saharan Africa--a systematic review and meta-analysis.Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialRetention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinicHigh prevalence of PI resistance in patients failing second-line ART in Vietnam.The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern TanzaniaShould viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settingsSecond-Line HIV Therapy Outcomes and Determinants of Mortality at the Largest HIV Referral Center in Southern Vietnam.HIV in Africa: Challenges and Directions for the Next Decade.Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps.
P2860
Q28481468-3446E299-DA2C-4F25-B61A-C078EFA62EE5Q28535483-F5DBF8E2-2830-4682-8D9D-BB4E564F2918Q30911364-47C97947-F9A1-40AB-9086-E2E00CBE30A8Q33712438-D350BB82-5554-4669-987B-AB821B42ABBBQ33832833-4561E558-0076-481E-BD77-B35D28716818Q34292437-C177F1C2-5099-4D2E-9550-FB33A5B37B8BQ34464667-F68BD8EA-9027-4CDA-B0A3-17F683DD0890Q34625910-9E708FA6-9C4E-4F0E-8EF7-A0E6ADD94CB5Q34801978-D91E325E-2C6D-4D26-9F95-B61C70ABD437Q34998736-6B5173C5-54B7-4C41-8C1E-78706699C137Q35049762-7ADCCB4E-458F-46BB-A247-2395520BAC6CQ35077695-B8706C31-7B0E-4D06-83E1-9A0E50B1B7BBQ36109276-DC320544-EA4B-4482-91AB-D280837D842CQ36179320-64C1712C-FE5D-43DC-BCA7-0273830E10D7Q36460759-95FC24B4-1B54-4DF9-A941-83915224E4E3Q36551309-ACD747F8-E1B3-4881-BCCF-540324CF5A1DQ36645016-2EDE9CA0-2B04-4797-8668-6E3474FCCDEEQ37116750-82C6C79B-ADA2-4339-AB66-CDDC44683A01Q37176147-6A80D3C7-797C-469B-B704-EB16B369CE34Q38419599-9E4CCAC9-1DA4-4924-947C-FC7051B86007Q38848107-E4C29179-1AD5-4A8A-B75C-5B9EF4F0455DQ40088992-6FA3227F-1B37-4F24-9CCB-C85ECA375C67
P2860
Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Early outcomes and the virolog ...... out programme in South Africa.
@ast
Early outcomes and the virolog ...... out programme in South Africa.
@en
type
label
Early outcomes and the virolog ...... out programme in South Africa.
@ast
Early outcomes and the virolog ...... out programme in South Africa.
@en
prefLabel
Early outcomes and the virolog ...... out programme in South Africa.
@ast
Early outcomes and the virolog ...... out programme in South Africa.
@en
P2860
P50
P921
P356
P1433
P1476
Early outcomes and the virolog ...... out programme in South Africa.
@en
P2093
Julie H Levison
Zhigang Lu
P2860
P304
P356
10.3851/IMP1819
P577
2011-01-01T00:00:00Z